Edo State has reported a total of 240 confirmed cases of Lassa fever and 21 deaths from December to March 2024.
This was revealed by Dr. Joseph Okoeguale, the Director of Viral and Emergent Pathogens Control and Research at Irrua Specialist Teaching Hospital.
The alarming statistics reveal the ongoing challenge of this disease, which poses a health risk to approximately 37.7 million people across 14 West African nations, resulting in over 5,000 deaths annually.
Dr. Okoeguale shared this information during a lecture on advancing research and development efforts related to Lassa fever at Edo State University Uzairue.
He emphasized that only 20 percent of infected individuals show symptoms, while the remaining 80 percent remain asymptomatic and often do not seek medical help.
This lack of awareness complicates efforts to combat the disease.
The consultant highlighted that preventing the spread of Lassa fever through vaccination is crucial.
He pointed out that the outbreak occurs annually, affecting individuals of all ages and contributing to ongoing health system strain in Nigeria.
To address this, the World Health Organization has identified Lassa fever as a priority for research, and several centers of excellence have been established to enhance diagnostic and treatment capabilities.
Dr. Okoeguale also mentioned the establishment of a new clinical trial and sequencing center aimed at developing innovative drugs and vaccines for Lassa fever.
 Collaborations are in place with international health organizations to enhance clinical management and research on this infectious disease.
The Acting Vice Chancellor of Edo State University, Prof. Dawood Egbefo, reinforced the importance of addressing the public health crisis posed by Lassa fever, noting its widespread impact on both local communities and the national healthcare system.
